title: Thrombolytic Therapy Targeting Alpha 2-Antiplasmin.
authors.affiliation: From Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan. uranot@hama-med.ac.jp.
authors.forename: Tetsumei
authors.initials: T
authors.lastname: Urano
authors.affiliation: From Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
authors.forename: Yuko
authors.initials: Y
authors.lastname: Suzuki
mesh_terms: D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D006801:Humans; D010958:Plasminogen; D011655:Pulmonary Embolism; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator; D000979:alpha-2-Antiplasmin
chemical_list: D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D000979:alpha-2-Antiplasmin; D010958:Plasminogen; D010959:Tissue Plasminogen Activator
keywords: Editorials; plasminogen activator; pulmonary embolism; thrombolysis